Henrik Lind • 1983 • Nesøya • 12 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
D DANZIG AS	Managing Director/CEO	382,197	989,056	100 % directly
H HCL AS	Managing Director/CEO	4,127,380	-328,350	100 % indirectly
M MEDPOINT AS	Managing Director/CEO	3,786,746	1,200,637	33.33 % indirectly
E EPSYK AS	Managing Director/CEO	2,235,744	333,979	23.75 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
D DANZIG AS	Chairman	382,197	989,056	100 % directly
H HCL AS	Chairman	4,127,380	-328,350	100 % indirectly
F FORTFRISK AS	Chairman	1,094,537	-624,960	50.03 % indirectly
N NOOB PHARMA AS	Chairman	4,000	-16,349	50 % indirectly
M MEDPOINT AS	Board Member	3,786,746	1,200,637	33.33 % indirectly
M MEDPOINT AS	Board Member	1,200	555,593	25 % indirectly
E EPSYK AS	Board Member	2,235,744	333,979	23.75 % indirectly
H HENRIK CHRISTER LIND	Holder	-	-	-

Last update: Apr 13, 2023

Related industries2

Direct relationships3

CT
Christer Torgilstveit Larsen1985
FORTFRISK AS, MEDPOINT AS, MEDPOINT AS, NOOB PHARMA AS, EPSYK AS
PA
Peder Anker1985
MEDPOINT AS, MEDPOINT AS
LK
Lars Kristian Gullestad1985
MEDPOINT AS

Shares owned by Henrik Lind

Name	Share class	Total operating income	Total equity	Share
D DANZIG AS	Ordinære aksjer	382,197	989,056	100 % directly
H HCL AS		4,127,380	-328,350	100 % indirectly
F FORTFRISK AS		1,094,537	-624,960	50.03 % indirectly
N NOOB PHARMA AS		4,000	-16,349	50 % indirectly
M MEDPOINT AS		3,786,746	1,200,637	33.33 % indirectly
M MEDPOINT AS		1,200	555,593	25 % indirectly
E EPSYK AS		2,235,744	333,979	23.75 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025